These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 8598612)
1. Cost-effectiveness of stroke prophylaxis for nonvalvular atrial fibrillation. Kan BD; Katz DA JAMA; 1996 Mar; 275(12):909; author reply 910. PubMed ID: 8598612 [No Abstract] [Full Text] [Related]
2. Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation. Gage BF; Cardinalli AB; Albers GW; Owens DK JAMA; 1995 Dec; 274(23):1839-45. PubMed ID: 7500532 [TBL] [Abstract][Full Text] [Related]
3. Cost Effectiveness of Apixaban versus Warfarin or Aspirin for Stroke Prevention in Patients with Atrial Fibrillation: A Greek Perspective. Athanasakis K; Boubouchairopoulou N; Karampli E; Tarantilis F; Savvari P; Bilitou A; Kyriopoulos J Am J Cardiovasc Drugs; 2017 Apr; 17(2):123-133. PubMed ID: 27882517 [TBL] [Abstract][Full Text] [Related]
4. Should hemodialysis patients with atrial fibrillation undergo systemic anticoagulation? A cost-utility analysis. Quinn RR; Naimark DM; Oliver MJ; Bayoumi AM Am J Kidney Dis; 2007 Sep; 50(3):421-32. PubMed ID: 17720521 [TBL] [Abstract][Full Text] [Related]
5. Warfarin versus aspirin in the elderly in primary prophylaxis for atrial fibrillation. Morrison CM; Gainsborough N; Rajkumar C Age Ageing; 2007 Mar; 36(2):117-9. PubMed ID: 17255089 [No Abstract] [Full Text] [Related]
7. Warfarin sodium or aspirin therapy to prevent stroke in nonrheumatic atrial fibrillation. Answered and unanswered questions. Stratton JR West J Med; 1995 Aug; 163(2):177-9. PubMed ID: 7571577 [No Abstract] [Full Text] [Related]
8. Cost-effectiveness of different strategies for stroke prevention in patients with atrial fibrillation in a health resource-limited setting. Wu B; Kun L; Liu X; He B Cardiovasc Drugs Ther; 2014 Feb; 28(1):87-98. PubMed ID: 24048510 [TBL] [Abstract][Full Text] [Related]
9. Replacing aspirin and warfarin for secondary stroke prevention: is it worth the costs? Hankey GJ Curr Opin Neurol; 2010 Feb; 23(1):65-72. PubMed ID: 19949330 [TBL] [Abstract][Full Text] [Related]
14. Aspirin and prevention of stroke. Morocutti C; Coccheri S Lancet; 1994 Jan; 343(8891):234. PubMed ID: 7904685 [No Abstract] [Full Text] [Related]
15. [Atrial fibrillation due to non-valvular causes: indications for antithrombotic therapy]. Codinach Huix P Med Clin (Barc); 1996 Apr; 106(15):586-9. PubMed ID: 8656759 [No Abstract] [Full Text] [Related]
16. Additional risk factors in atrial fibrillation patients not receiving warfarin. Wensley S; Keir S; Caine S; Mac Mahon M Age Ageing; 1999 Jul; 28(4):355-7. PubMed ID: 10459787 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of clopidogrel plus aspirin for stroke prevention in patients with atrial fibrillation in whom warfarin is unsuitable. Coleman CI; Straznitskas AD; Sobieraj DM; Kluger J; Anglade MW Am J Cardiol; 2012 Apr; 109(7):1020-5. PubMed ID: 22221944 [TBL] [Abstract][Full Text] [Related]
18. [Clinical study of the month. Prevention of cerebral vascular accidents in patients with atrial fibrillation]. Scheen AJ Rev Med Liege; 1999 Jun; 54(6):561-3. PubMed ID: 10446529 [TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation and stroke prevention in the community. O'Connell JE; Gray CS Age Ageing; 1996 Jul; 25(4):307-9. PubMed ID: 8831876 [TBL] [Abstract][Full Text] [Related]